OCTIVUS shows PCI outcomes improve with EAPCI-defined stent optimization, regardless of imaging modality. MITT and safety data show acoramidis significantly lowers AFib-related events in transthyretin cardiac amyloidosis. LuX-Valve offers a safe, effective option for severe TR patients at high surgical risk. ESC 2025: Acoramidis may reduce AF/flutter burden in ATTR-CM, per new ATTRibute-CM trial analysis discussed by CardioNerds. CTA-first screening before TAVR avoids invasive angiography in 53% of patients—without compromising outcomes. Delays in TAVI for acute decompensated aortic stenosis worsen outcomes. Explore evolving LV unloading strategies in AMI shock with The CardioNerds. Pulmonary air embolism causing RV failure & arrest—via ocular route? A rare case, deep dive, with The CardioNerds. NAVULTRA registry compares Navitor vs. SAPIEN 3 Ultra in TAVR, revealing key tradeoffs in pacemaker use, PVL, and HF outcomes Dr. Daniel Judge discusses how the ATTRibute-CM trial marks a turning point in ATTR cardiomyopathy treatment and research. The FDA approved the use of Edwards Lifesciences' SAPIEN 3 TAVR platform for patients with severe aortic stenosis. Dr. Dan Judge speaks to The CardioNerds about his interpretation of the primary findings from ATTRibute-CM. Dr. Daniel Judge talks to the CardioNerds about a pivotal study in ATTR-CM. A multifaceted approach is necessary to reduce the deaths of smoking-related aortic aneurysms. Many preschool-aged children with congenital heart conditions are not on track for school readiness. The CardioNerds talk about the professional challenges ACHD providers face across the lifespan of congenital heart disease. Dr. Amit Goyal of the CardioNerds analyzed the BHF PROTECT-TAVI trial. The REPAIR study offers the most comprehensive real-world assessment of outcomes after mitral TEER. The CardioNerds, along with colleagues detail a case involving a patient with newly diagnosed hypertriglyceridemia. The ROLLER COASTR-EPIC22 trial is the first randomized head-to-head comparison of three plaque modification techniques.